Hospital
Powell Valley Health Care INC
Powell Valley Health Care INC was paid $172K by Medicaid between Jan 2018 and Oct 2024, across 12 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 47% of everything it billed.
33Billing provider infoPOWELL VALLEY HEALTH CARE INC
POWELL, WY 82435
POWELL, WY 82435
33aNPI1497753115assigned 07/08/2005
33bProvider typeRural Acute Care Hospital
28Total paid$172K
24GClaims2,826
24DCodes billed12
24AFirst – last monthJan 2018 – Oct 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 80 | $2K | |
| 2019 | 60 | $3K | |
| 2020 | 137 | $11K | |
| 2021 | 586 | $28K | |
| 2022 | 915 | $54K | |
| 2023 | 618 | $45K | |
| 2024incomplete | 430 | $29K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 47% | 605 | 493 | $80K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 28% | 598 | 541 | $49K |
| A0425 | Ground mileage, per statute mile | 11% | 304 | 203 | $19K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7.1% | 138 | 137 | $12K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.3% | 39 | 24 | $6K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.2% | 339 | 130 | $2K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.1% | 24 | 15 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 62 | 27 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 524 | 395 | $561.21 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 17 | 14 | $120.72 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 69 | 53 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 107 | 80 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialODOM, TERRY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Terry W Odom Pediatrics | Amory, MS | $1.11M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.